bioRxivBiophysicsPreprint
All-atom MD simulations of the HPV16 capsid
Abstract
Human papillomavirus (HPV) type 16, one of over 200 known genotypes, is a major cause of anogenital and oropharyngeal cancers worldwide. The L1 protein capsid - which represents the exterior shell of the virus - plays essential roles in host cell adhesion and entry, and is the major antigen used in vaccines that protect against HPV. Here we report an all-atom molecular dynamics (MD) simulation of the intact capsid in explicit solvent, a calculation comprising 16.8 million atoms. The detailed motions and emergent biophysical properties revealed by this simulation provide critical insights into capsid function and immunogenicity, establishing a new platform for rational drug design and antibody engineering.
- assay: protein structure
- research focus: drug response / drug discovery
- approach: mechanistic / dynamical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The human papillomavirus L2 protein in the capsid is an ensemble of related structures poised to exit the virus particle
Changin Oh, Huaxin Yu, … Daniel DiMaio·bioRxiv·Aug 21, 2026
- High resolution cryo EM analysis of HPV16 identifies minor structural protein L2 and describes capsid flexibility
D. J. Goetschius, S. R. Hartmann, … S. L. Hafenstein·bioRxiv·Oct 27, 2020
- Production of HPV16 capsid proteins in suspension cultures of human epithelial cells
D. Sakauchi, E. A. Sasaki, … A. M. Cianciarullo·bioRxiv·Oct 28, 2020
- Computational modeling of virucidal inhibition mechanism for broad-spectrum antiviral nanoparticles and HPV16 capsid segments
P. Chaturvedi, P. Kelich, … L. Vukovic·bioRxiv·Aug 21, 2021
- Glycan-induced structural activation softens the human papillomavirus capsid for entry through reduction of intercapsomere flexibility
Y. Feng, D. van Bodegraven, … W. H. Roos·bioRxiv·Feb 1, 2024
- HPV16 neutralizing monoclonal antibodies show evidence for common developmental pathways and public epitopes
Joseph J. Carter, Nicholas K. Hurlburt, … Denise A. Galloway·bioRxiv·Mar 31, 2025